Clinical Trials · NCT06449703
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects
- Phase
- Phase 1
- Recruitment status
- Unknown
- Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Enrollment
- 44
- Start date
- May 2024
- Locations
- 1 site, China
- Primary endpoint
- Maximum observed plasma insulin degludec concentration